Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Ns Pharma Inc.
Sponsor

Ns Pharma Inc.

United States 140 East Ridgewood Avenue Suite 280s, 07652-3914, United States

About the sponsor

Clinical research activity in neuromuscular disease includes studies of viltolarsen in boys with Duchenne Muscular Dystrophy, with attention to treatment tolerability and disease-focused care in a pediatric population.

  • Neuromuscular disorders
  • Pediatric genetic disease
  • Muscle degeneration

The sponsor’s work in this area centers on a rare inherited condition that affects skeletal muscle function and mobility.

About Specializations

Ns Pharma Inc. runs clinical trials in conditions such as Eosinophilic granulomatosis with polyangiitis, Duchenne muscular dystrophy, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Eosinophilic granulomatosis with polyangiitis

Recruiting
Investigational
Countries:FranceFrance
  • Participants:18–64 years · 65+ years
  • Substances:Methyl-(1-{[6-{[(1S)-1-Cyclopropylethyl]Amino}-2-(Pyrazolo[5,1-B][1,3]Thiazol-7-Yl)-Pyrimidin-4-Yl]Carbonyl}Piperidin-4-Yl)Carbamate-Mono(4-Methylbenzenesulfonate) Monohydrate
  • Sponsor:Ns Pharma Inc.

Duchenne muscular dystrophy

Not recruiting
InvestigationalNo placebo
Countries:CzechiaCzechia
  • Participants:0–17 years
  • Substances:Viltolarsen
  • Sponsor:Ns Pharma Inc.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.